← Leaderboards
Kimberley M El
Duke University
$424,116
Attributed
$424,116
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $107.2K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$424,116 · 1
By mechanism
K01$424,116 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- John Andrew Mackay$5,232,024
- Jonathan E Campbell$4,360,286
- Lee W Jones$15,873,984
- Douglas A Marchuk$20,574,970
- Cathrine Hoyo$22,947,053
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignAcuteDangerousnessCounterregulationAmino AcidsArginineAutomobile DrivingAlanineAdrenal GlandsBiologyBlood GlucoseBrainCarbohydratesCarbonCareerCatecholaminesAwarenessCell PhysiologyCellsAlpha CellCognitionComplexComplicationDiabetes Mellitus
Grant awards (4)
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia$105,654
K01 · FY2025 · DK · contact PI
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia$105,654
K01 · FY2024 · DK · contact PI
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia$105,654
K01 · FY2023 · DK · contact PI
Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia$107,154
K01 · FY2022 · DK · contact PI